These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18793611)

  • 1. p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation.
    Sun WT; Hsieh PC; Chiang ML; Wang MC; Wang FF
    Biochem Biophys Res Commun; 2008 Nov; 376(2):395-8. PubMed ID: 18793611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis.
    Cao Y; Hamada T; Matsui T; Date T; Iwabuchi K
    Biochem Biophys Res Commun; 2004 Mar; 315(4):788-95. PubMed ID: 14985081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis.
    Uhlmann-Schiffler H; Kiermayer S; Stahl H
    Oncogene; 2009 May; 28(20):2065-73. PubMed ID: 19377511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the structure and protein-protein interactions of the pro-apoptotic protein ASPP2.
    Rotem S; Katz C; Friedler A
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):966-9. PubMed ID: 17956256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway.
    Hsieh PC; Chang JC; Sun WT; Hsieh SC; Wang MC; Wang FF
    Oncogene; 2007 Jul; 26(34):4928-40. PubMed ID: 17310996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53.
    Liu ZJ; Lu X; Zhang Y; Zhong S; Gu SZ; Zhang XB; Yang X; Xin HM
    FEBS Lett; 2005 Mar; 579(7):1587-90. PubMed ID: 15757645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage.
    Hsieh WJ; Hsieh SC; Chen CC; Wang FF
    Biochem Biophys Res Commun; 2008 May; 369(2):567-72. PubMed ID: 18291097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins.
    Benyamini H; Friedler A
    J Mol Recognit; 2011; 24(2):266-74. PubMed ID: 20623514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation.
    Miao L; Song Z; Jin L; Zhu YM; Wen LP; Wu M
    Oncogene; 2010 Feb; 29(5):711-22. PubMed ID: 19901969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHL2 mediates p53-induced transcriptional activation through a direct association with HIPK2.
    Lee SW; Kim EJ; Um SJ
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1056-62. PubMed ID: 16343438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel isoform of iASPP and its interaction with p53.
    Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
    J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53.
    Helps NR; Barker HM; Elledge SJ; Cohen PT
    FEBS Lett; 1995 Dec; 377(3):295-300. PubMed ID: 8549741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASPP1 and ASPP2: common activators of p53 family members.
    Bergamaschi D; Samuels Y; Jin B; Duraisingham S; Crook T; Lu X
    Mol Cell Biol; 2004 Feb; 24(3):1341-50. PubMed ID: 14729977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASPP1 and ASPP2 are new transcriptional targets of E2F.
    Fogal V; Kartasheva NN; Trigiante G; Llanos S; Yap D; Vousden KH; Lu X
    Cell Death Differ; 2005 Apr; 12(4):369-76. PubMed ID: 15731768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.
    Slee EA; Gillotin S; Bergamaschi D; Royer C; Llanos S; Ali S; Jin B; Trigiante G; Lu X
    Oncogene; 2004 Dec; 23(56):9007-16. PubMed ID: 15489900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
    Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
    Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the interaction of the regulatory protein Ki-1/57 with p53 and its interacting proteins.
    Nery FC; Rui E; Kuniyoshi TM; Kobarg J
    Biochem Biophys Res Commun; 2006 Mar; 341(3):847-55. PubMed ID: 16455055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gemin3 inhibits cell apoptosis through suppression of p53 expression].
    Guo Y; Zhang XG; Zhao N; Li TR; Li H
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):810-5. PubMed ID: 22335944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of 53BP2 and ASPP2 proteins from TP53BP2 gene by alternative splicing.
    Takahashi N; Kobayashi S; Jiang X; Kitagori K; Imai K; Hibi Y; Okamoto T
    Biochem Biophys Res Commun; 2004 Mar; 315(2):434-8. PubMed ID: 14766226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation.
    Zhou J; Qiao X; Xiao L; Sun W; Wang L; Li H; Wu Y; Ding X; Hu X; Zhou C; Zhang J
    FEBS Lett; 2010 Mar; 584(6):1085-90. PubMed ID: 20159018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.